Precision BioSciences Inc. (NASDAQ: DTIL)
$6.0000
+1.5000 ( -11.77% ) 13.2M
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Market Data
Open
$6.0000
Previous close
$4.5000
Volume
13.2M
Market cap
$34.52M
Day range
$4.7800 - $7.9080
52 week range
$3.6100 - $19.4299
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 31, 2024 |
4 | Insider transactions | 1 | Dec 31, 2024 |
4 | Insider transactions | 1 | Dec 30, 2024 |
4 | Insider transactions | 1 | Nov 21, 2024 |
4 | Insider transactions | 1 | Nov 05, 2024 |
4 | Insider transactions | 1 | Nov 05, 2024 |
4 | Insider transactions | 1 | Nov 05, 2024 |
8-k | 8K-related | 12 | Nov 04, 2024 |
10-q | Quarterly Reports | 73 | Nov 04, 2024 |
8-k | 8K-related | 12 | Oct 24, 2024 |